ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 135 filers reported holding ASCENDIS PHARMA A/S in Q2 2019. The put-call ratio across all filers is 0.27 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $9,614,000 | -14.6% | 65,000 | -35.0% | 0.27% | -43.5% |
Q1 2020 | $11,261,000 | -19.1% | 100,000 | 0.0% | 0.48% | -11.4% |
Q4 2019 | $13,912,000 | -3.7% | 100,000 | -33.3% | 0.54% | -7.3% |
Q3 2019 | $14,448,000 | -16.4% | 150,000 | 0.0% | 0.58% | -17.2% |
Q2 2019 | $17,273,000 | +17.4% | 150,000 | +20.0% | 0.70% | +16.3% |
Q1 2019 | $14,713,000 | – | 125,000 | – | 0.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |